ORCLSeptember 9, 2026 at 11:43 AM UTCSoftware & Services

Oracle's Record Backlog Clashes with Cash Burn, Fueling Wall Street Divide

Read source article

What happened

Oracle's stock has fallen about 39% from its recent high even as it reported a record $638B remaining performance obligation, up from $138B a year earlier. The reason for the disconnect is that only about 12% of that backlog is expected to convert to revenue within 12 months, while the company's aggressive AI infrastructure buildout caused FY2026 free cash flow to plunge to -$23.7B. To fund the expansion, Oracle plans roughly $40B of additional financing in FY2027, including a $20B at-the-market equity program, which raises dilution concerns. Wall Street is split between those who see the backlog as evidence of unassailable AI demand and those who argue the company is over-earning on promises that may take years to materialize into cash. The next major test is Q1 FY2027 results in mid-September, where cloud growth must land in the 58-64% guided range to validate the thesis that capacity is converting quickly enough.

Implication

Near term, Oracle's stock may remain volatile as the market digests the gap between its record backlog and steep negative free cash flow. The critical risk is that if cloud growth misses guidance or the RPO conversion rate stays at 12%, the financing burden will worsen and could trigger ATM usage, further diluting shareholders. Conversely, if Q1 shows cloud growth above 64% and customer prepayments rise, the stock could re-rate higher as the AI monetization story gains credibility. We recommend monitoring the September earnings and the subsequent quarterly filing for changes in RPO timing, prepayment balances, and any ATM activity, as these will determine whether the WAIT rating should shift to BUY or SELL. Until then, the stock offers insufficient margin of safety; an attractive entry point remains near $135 if the thesis weakens, while upside to $185-190 is possible if execution exceeds expectations.

Thesis delta

No material change to the investment thesis: Oracle remains a WAIT due to the unresolved tension between enormous AI demand and weak near-term cash conversion. However, the article underscores that the market is now explicitly debating whether the backlog is a leading indicator of value or a lagging indicator of overcommitment, which slightly increases the importance of the upcoming Q1 FY2027 report as a decisive catalyst.

Confidence

Moderate